Cited by 146Acute Myeloid Leukemia ResearchCancer Genomics and DiagnosticsChromatin Remodeling and Cancer

Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A

Buscarlet, Manuel, Provost, Sylvie, Zada, Yassamin Feroz, Bourgoin, Vincent, Mollica, Luigina, Dubé, Marie-Pierre, Busque, Lambert·2018·Blood

Abstract

We analyzed DNA from polymorphonuclear (PMN) cells, monocytes, B cells, and T cells of 107 individuals with clonal hematopoiesis of indeterminate potential (CHIP) to perform lineage restriction analysis of different gene mutations. Three lineage categories were defined: myeloid (PMN with or without monocytes), myelolympho-B (myeloid and B cells), and multipotent (myeloid, B and T cells). Six individuals with aberrant patterns were excluded from analysis. Ninety-four had a single mutation (56 in DNMT3A , 24 in TET2 , 7 in other genes [ JAK2 , ASXL1 , CBL or TP53 ]). Fourteen had multiple mutations. The lineage restriction patterns of single DNMT3A - or TET2 -mutated individuals were different. The proportion of myeloid restricted mutations was higher for TET2 (54.2%, 13 of 24) than for DNMT3A (23.2%, 13 of 56) ( P TET2 individuals ( P TET2 mutation in the multipotent category in contrast to 35.7% (20 of 56) for DNMT3A ( P DNMT3A suggesting a time delay for extensive lineage clonal dominance. These distinctive features may be important in deciphering the transformation mechanisms of these frequent mutations.

Integrity signals

Registry

Crossref · 10.1182/blood-2018-01-829937

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Buscarlet, M., Provost, S., Zada, Y. F., Bourgoin, V., Mollica, L., Dubé, M.-P., & Busque, L.
Affiliations
  • Hôpital Maisonneuve-Rosemont (CA)
  • Montreal Heart Institute (CA)
Venue
Blood
Published
2018-07-19
Volume
132
Issue
3
Pages
277-280
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2803478601
Cited by
146
References
4
Citations by year
2026: 15 · 2025: 12 · 2024: 22 · 2023: 18 · 2022: 17 · 2021: 19 · 2020: 27 · 2019: 13 · 2018: 3
FWCI
11.11
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Funders
Canadian Institutes of Health Research
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
TET2, DNMT3A, clonal hematopoiesis, CHIP, lineage restriction, myeloid bias, multipotent stem cells, clonal dominance, clonal evolution
MeSH terms
DNA Methyltransferase 3A, Aged, Aged, 80 and over, Cell Differentiation, DNA (Cytosine-5-)-Methyltransferases, DNA-Binding Proteins, Female, Humans, Male, Middle Aged, Models, Biological, Mutation, Proto-Oncogene Proteins, Biomarkers, Cell Lineage, Multipotent Stem Cells, Chromatin Immunoprecipitation, Dioxygenases, High-Throughput Nucleotide Sequencing, Clonal Evolution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review